TIDMTSP

RNS Number : 6367Y

TruSpine Technologies PLC

09 May 2023

9 May 2023

TruSpine Technologies plc

("TruSpine" or the "Company")

Update re Loan

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces an update to the announcement released by the Company on 28 February 2023 in relation to the Loan Agreement entered into by the Company.

The announcement of 28 February 2023 omitted to disclose a fixed and floating charge over the Company's intellectual property to the lender as security for the proceeds of which were received on 27 February 2023. A registration of charge was registered on Companies House in relation to this matter on 28 April 2023.

Capitalised terms used in this announcement shall, unless otherwise defined, have the same meanings as set out in the Company's announcement of 28 February 2023.

This announcement contains inside information for the purposes of the UK Market Abuse Regulation, and the Directors of the Company are responsible for the release of this announcement.

Enquiries:

 
 TruSpine Technologies Plc                                         Tel: +44 (0)20 7118 0852 
 Laurence Strauss, Chief Executive Officer 
 
 Cairn Financial Advisers LLP (AQSE Corporate Adviser)             Tel: +44 (0)20 7213 0880 
 Liam Murray / Ludovico Lazzaretti 
 Oberon Capital (Joint Broker) 
                                                                   Tel: +44 (0)20 3179 5300 
 Mike Seabrook / Chris Crawford 
 Peterhouse Capital Limited (Joint Broker & Financial Adviser) 
                                                                   Tel: +44 (0)20 7469 0930 
 Lucy Williams / Duncan Vasey 
 Novus Communications (PR and IR)                                  Tel: +44 (0)207 448 9839 
 Alan Green / Jacqueline Briscoe                                    novuscomms@truspine.org

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identi ed by their use of terms and phrases such as "believe", "could", "should" "envisage", "estimate", "intend", "may", "plan", "potentially", "expect", "will" or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements re ect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXSSMFIIEDSEDI

(END) Dow Jones Newswires

May 09, 2023 02:00 ET (06:00 GMT)

TruSpine Technologies (AQSE:TSP)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more TruSpine Technologies Charts.
TruSpine Technologies (AQSE:TSP)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more TruSpine Technologies Charts.